Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BMEA
BMEA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BMEA News
Biomea Fusion Completes Chronic Toxicology Studies for Icovamenib
5h ago
Newsfilter
Biomea Fusion Q1 Earnings Beat Expectations
1h ago
seekingalpha
Biomea Fusion Announces Late-Breaking Presentations at ADA Conference
6d ago
Newsfilter
Major Wall Street Rating Updates
6d ago
CNBC
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Biomea Fusion Reports Positive 52-Week Results for Icovamenib in Type 1 Diabetes Trial
Apr 28 2026
NASDAQ.COM
Biomea Fusion Reports Positive Results for Diabetes Treatment
Apr 27 2026
Newsfilter
Biomea Fusion Reports FY 2025 Earnings Results
Mar 24 2026
seekingalpha
Biomea Fusion Reports Positive Results from Diabetes Study
Mar 14 2026
Yahoo Finance
Biomea Fusion to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Dec 17 2025
Globenewswire
Biomea Fusion Unveils Clinical Results of Icovamenib, Advancing Diabetes Treatment
Dec 10 2025
Globenewswire
Biomea Fusion Unveils Clinical Results of Icovamenib, Advancing Diabetes Treatment
Dec 10 2025
Newsfilter
Biomea Fusion Highlights Long-lasting Advantages of Menin Inhibitor for Type 2 Diabetes
Dec 05 2025
NASDAQ.COM
Biomea Fusion Presents COVALENT-111 Study Results, New Breakthrough in Diabetes Treatment
Dec 05 2025
Globenewswire
Biotech Stocks Rise After Hours: Clene Jumps Ahead of ALS Update; Werewolf, Biomea, and Dyne Also Gain
Dec 03 2025
NASDAQ.COM
Biomea Fusion Grants 7,500 Stock Options to New Employee
Dec 01 2025
Newsfilter
Show More News
